Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: The clinical significance of FAM19A4 methylation in high-risk HPV-positive cervical samples for the detection of cervical (pre)cancer in Chinese women

Fig. 3

The diagnostic power of FAM19A4 methylation, cytology, HPV16/18 genotyping and the combination of FAM19A4 methylation and HPV16/18 genotyping. (a) Power of FAM19A4 methylation, cytology, HPV16/18 genotyping and the combination of FAM19A4 methylation and HPV16/18 genotyping in differentiating ≥HSIL patients from ≤LSIL patients. (b) Power of FAM19A4 methylation, cytology, HPV16/18 genotyping and the combination of FAM19A4 methylation and HPV16/18 genotyping in differentiating HSIL patients from ≤LSIL patients

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us